OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
October 02, 2002
The European Union is attempting to reform its current business environment in hopes of restoring its role in the lobal R&D sector.
September 02, 2002
The author discusses the potential effect on CROs of pending major-pharma mergers and consolidations.
When choosing a CRO, take the time to conduct an in-depth evaluation of each department, paying special attention to the quality and training of its personnel.
August 01, 2002
The author examines the concept of evaluating CRO operating performance in today's pharmaceutical industry.
The results of this 2002 survey of contract services decision makers reviews and forecasts the state of the outsourcing industry.
July 01, 2002
Carefully crafted outsourcing arrangements allow companies to become powerful partners in the quest for market share.
The author discusses the Japanese cabinet's approval of a measure that lifts manufacturing restrictions on domestic pharmaceutical companies.
June 01, 2002
The author discusses the upcoming human research congressional debate and CROs' preparations to respond.
Treating a cross-organizational team as a full-fledged partnership helps complete a project on time and on budget.
A profile about how a provider with a solid reputation in niche areas of contract manufacturing became a full-service operation.